Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Intranasal Naloxone Under Remifentanil Influence
NCT02307721Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Dec 2014
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of naloxone in opioid overdose (2 arms), sponsored by Norwegian University of Science and Technology. Primary endpoints: Pharmacodynamic profile of naloxone - Heat Pain Threshold at 120 minutes and Pharmacodynamic profile of naloxone - Pupillometry at 120 minutes. Started Dec 2014; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT02307721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307721.